Literature DB >> 16288392

Antibiotic prescription for community-acquired pneumonia in the intensive care unit: impact of adherence to Infectious Diseases Society of America guidelines on survival.

M Bodí1, A Rodríguez, J Solé-Violán, M C Gilavert, J Garnacho, J Blanquer, J Jimenez, M V de la Torre, J M Sirvent, J Almirall, A Doblas, J R Badía, F García, A Mendia, R Jordá, F Bobillo, J Vallés, M J Broch, N Carrasco, M A Herranz, J Rello.   

Abstract

BACKGROUND: The purpose of our study was to analyze prognostic factors associated with mortality for patients with severe community-acquired pneumonia (CAP).
METHODS: We conducted a prospective multicenter study including all patients with CAP admitted to the intensive care unit during a 15-month period in 33 Spanish hospitals. Admission data and data on the evolution of the disease were recorded. Multivariate analysis was performed using the SPSS statistical package (SPSS).
RESULTS: A total of 529 patients with severe CAP were enrolled; the mean age (+/-SD) was 59.9+/-16.1 years, and the mean Acute Physiology and Chronic Health Evaluation (APACHE) II score (+/-SD) was 18.9+/-7.4. Overall mortality among patients in the intensive case unit was 27.9% (148 patients). The rate of adherence to Infectious Diseases Society of America (IDSA) guidelines was 57.8%. Significantly higher mortality was documented among patients with nonadherence to treatment (33.2% vs. 24.2%). Multivariate analysis identified age (odds ratio [OR], 1.7), APACHE II score (OR, 4.1), nonadherence to IDSA guidelines (OR, 1.6), and immunocompromise (OR, 1.9) as the variables present at admission to the intensive care unit that were independently associated with death in the intensive care unit. In 15 (75%) of 20 cases of Pseudomonas aeruginosa infection, the antimicrobial treatment at admission was inadequate (including 8 of 15 cases involving patients with adherence to IDSA guidelines). Chronic obstructive pulmonary disease (OR, 17.9), malignancy (OR, 11.0), previous antibiotic exposure (OR, 6.2), and radiographic findings demonstrating rapid spread of disease (OR, 3.9) were associated with P. aeruginosa pneumonia.
CONCLUSIONS: Better adherence to IDSA guidelines would help to improve survival among patients with severe CAP. Pseudomonas coverage should be considered for patients with chronic obstructive pulmonary disease, malignancy, or recent antibiotic exposure.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16288392     DOI: 10.1086/498119

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  42 in total

1.  The use of three strategies to improve quality of care at a national level.

Authors:  Jeannette P P So; James G Wright
Journal:  Clin Orthop Relat Res       Date:  2012-04       Impact factor: 4.176

Review 2.  Systematic review and meta-analysis of the efficacy of appropriate empiric antibiotic therapy for sepsis.

Authors:  Mical Paul; Vered Shani; Eli Muchtar; Galia Kariv; Eyal Robenshtok; Leonard Leibovici
Journal:  Antimicrob Agents Chemother       Date:  2010-08-23       Impact factor: 5.191

Review 3.  Optimal therapy for severe pneumococcal community-acquired pneumonia.

Authors:  Manel Luján; Miguel Gallego; Jordi Rello
Journal:  Intensive Care Med       Date:  2006-05-10       Impact factor: 17.440

4.  Severity of illness assessment for managing community-acquired pneumonia.

Authors:  Jordi Rello; Alejandro Rodriguez
Journal:  Intensive Care Med       Date:  2007-10-16       Impact factor: 17.440

5.  Severe community-acquired pneumonia and PIRO: a new paradigm of management.

Authors:  Jordi Rello; Thiago Lisboa; Richard Wunderink
Journal:  Curr Infect Dis Rep       Date:  2009-09       Impact factor: 3.725

Review 6.  Elderly patients with community-acquired pneumonia: optimal treatment strategies.

Authors:  Ulrich Thiem; Hans-Jürgen Heppner; Ludger Pientka
Journal:  Drugs Aging       Date:  2011-07-01       Impact factor: 3.923

Review 7.  Community-acquired pneumonia: identification and evaluation of nonresponders.

Authors:  João Gonçalves-Pereira; Catarina Conceição; Pedro Póvoa
Journal:  Ther Adv Infect Dis       Date:  2013-02

8.  Healthcare-associated pneumonia: another nail in the coffin?

Authors:  Pieter Depuydt; Christian Brun-Buisson
Journal:  Intensive Care Med       Date:  2014-03-18       Impact factor: 17.440

9.  Combination antibiotic therapy with macrolides improves survival in intubated patients with community-acquired pneumonia.

Authors:  I Martin-Loeches; T Lisboa; A Rodriguez; C Putensen; D Annane; J Garnacho-Montero; M I Restrepo; J Rello
Journal:  Intensive Care Med       Date:  2009-12-02       Impact factor: 17.440

10.  Disparities of care for African-Americans and Caucasians with community-acquired pneumonia: a retrospective cohort study.

Authors:  Christopher R Frei; Eric M Mortensen; Laurel A Copeland; Russell T Attridge; Mary Jo V Pugh; Marcos I Restrepo; Antonio Anzueto; Brandy Nakashima; Michael J Fine
Journal:  BMC Health Serv Res       Date:  2010-05-27       Impact factor: 2.655

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.